Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

ClinicalTrials.gov ID: NCT06057402

Public ClinicalTrials.gov record NCT06057402. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 8, 2026, 8:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ELRANATAMAB POST TRIAL ACCESS: AN OPEN-LABEL, SINGLE-ARM STUDY FOR PARTICIPANTS WITH MULTIPLE MYELOMA CONTINUING FROM PFIZER-SPONSORED ELRANATAMAB CLINICAL STUDIES

Study identification

NCT ID: NCT06057402
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 4
Lead sponsor: Pfizer; Industry
Enrollment: 80 participants

Conditions and interventions

Conditions

Multiple Myeloma

Interventions

Elranatamab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 2, 2023
Primary completion: Feb 21, 2032
Completion: Feb 21, 2032
Last update posted: May 4, 2026

2023 – 2032

United States locations

U.S. sites: 9
U.S. states: 3
U.S. cities: 7

Facility	City	State	ZIP	Site status
UCHealth Poudre Valley Hospital	Fort Collins	Colorado	80524	Recruiting
UCHealth Harmony	Fort Collins	Colorado	80528	Recruiting
UCHealth Greeley Hospital	Greeley	Colorado	80634	Recruiting
Longs Peak Hospital	Longmont	Colorado	80504	Recruiting
UCHealth Longs Peak Medical Center	Longmont	Colorado	80504	Recruiting
UCHealth - Medical Center of the Rockies	Loveland	Colorado	80538	Recruiting
University of Miami Hospital and Clinics Deerfield Beach	Deerfield Beach	Florida	33442	Recruiting
University of Miami Hospital and Clinics - Griffin Cancer Research Building	Miami	Florida	33136	Recruiting
St. David's South Austin Medical Center	Austin	Texas	78704	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06057402, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 4, 2026 · Synced May 8, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06057402 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →